CASI Pharmaceuticals Inc. (NASDAQ: CASI)
$6.14
-0.1100 ( -1.76% ) 27.6K
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
Market Data
Open
$6.14
Previous close
$6.25
Volume
27.6K
Market cap
$82.28M
Day range
$5.91 - $6.30
52 week range
$1.90 - $8.48
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 1 | Jan 30, 2024 |
6-k | Quarterly Reports | 1 | Dec 15, 2023 |
6-k | Quarterly Reports | 1 | Dec 08, 2023 |
6-k | Quarterly Reports | 3 | Nov 14, 2023 |
6-k | Quarterly Reports | 3 | Nov 08, 2023 |
6-k | Quarterly Reports | 3 | Aug 11, 2023 |
6-k | Quarterly Reports | 3 | Aug 01, 2023 |
6-k | Quarterly Reports | 3 | Jul 20, 2023 |